Key result
Human rhinovirus 3C protease demonstrated superior cleavage of fusion proteins at 4°C compared to tobacco etch virus protease and maintained activity across various buffers, additives, and detergents.
HRV 3C protease demonstrates superior cleavage efficiency at 4°C compared to TEV protease and is robust across various buffer conditions, making it highly suitable for recombinant protein production.
This is the authors' abstract. We don't add key points for this paper.
Proteases are widely used to remove affinity and solubility tags from recombinant proteins to avoid potential interference of these tags with the structure and function of the fusion partner. In recent years, great interest has been seen in use of the human rhinovirus 3C protease owing to its stringent sequence specificity and enhanced activity. Like other proteases, activity of the human rhinovirus 3C protease can be affected in part by the buffer components and additives that are generally employed for purification and stabilization of proteins, hence, necessitate their removal by tedious and time-consuming procedures before proteolysis can occur. To address this issue, we examined the effect of elution buffers used for common affinity based purifications, salt ions, stability/solubility and reducing agents, and detergents on the activity of the human rhinovirus 3C protease using three different fusion proteins at 4°C, a temperature of choice for purification of many proteins. The results show that the human rhinovirus 3C protease performs better at 4°C than the frequently used tobacco etch virus protease and its activity was insensitive to most of the experimental conditions tested. Though number of fusion proteins tested is limited, we expect that these finding will facilitate the use of the human rhinovirus 3C protease in recombinant protein production for pharmaceutical and biotechnological applications.
Answers are grounded in this paper and cite their sources.
May aid low-temperature fusion protein cleavage in labs; hypothesis-generating and should not yet change standard protocols.
No takes yet. Share an insight, caveat, or question.
Ullah et al. (2016) studied Recombinant protein production. Human rhinovirus 3C protease vs. Tobacco etch virus (TEV) protease was evaluated on Cleavage efficiency of fusion proteins. Human rhinovirus 3C protease demonstrated superior cleavage of fusion proteins at 4°C compared to tobacco etch virus protease and maintained activity across various buffers, additives, and detergents.
Synapse has enriched 10 related papers. Consider them for comparative context: